U.S. Highbush Blueberry Council   Report issue

Foundation Phase 2 Phase 3
Founded: Folsom CA United States (2000)

Organization Overview

First Clinical Trial
2005
NCT01942746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

U.S. Highbush Blueberry Council

Active Ingredients

Drugs in Phase 3 Trials (1)

blueberry (8 trials)

Drugs in Phase 2 Trials (1)

blueberry allergenic extract (7 trials)

Drugs in Other Trials (3)

berry polyphenols (1 trial)

maltodextrin (1 trial)

vitis vinifera (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 5